Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
3.950
+0.050 (1.28%)
May 29, 2026, 4:00 PM EDT - Market closed
Evolent Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 166.01 | 177.99 | 163.5 | 206.59 | 202.69 | 341.97 |
Cash & Short-Term Investments | 166.01 | 177.99 | 163.5 | 206.59 | 202.69 | 341.97 |
Cash Growth | -36.83% | 8.86% | -20.86% | 1.93% | -40.73% | 2.58% |
Accounts Receivable | 314.16 | 309.86 | 414.68 | 446.75 | 254.68 | 130.6 |
Other Current Assets | 21.85 | 18.52 | 28.94 | 30.33 | 20.68 | 51.39 |
Total Current Assets | 502.01 | 506.37 | 607.12 | 683.67 | 478.05 | 523.96 |
Net Property, Plant & Equipment | 85.05 | 85.16 | 79.29 | 90.18 | 136.9 | 131.57 |
Other Intangible Assets | 569.68 | 584.94 | 680.16 | 752.01 | 442.78 | 279.78 |
Goodwill | 694.43 | 694.48 | 1,137 | 1,117 | 722.77 | 426.3 |
Long-Term Investments | 8.96 | 8.97 | 8.59 | 4.9 | 4.48 | 5.46 |
Other Long-Term Assets | 18.72 | 19.32 | 31.95 | 33.01 | 32.31 | 52.39 |
Total Assets | 1,879 | 1,899 | 2,544 | 2,680 | 1,817 | 1,419 |
Accounts Payable | 63.01 | 59.78 | 96.03 | 48.25 | 57.17 | 96.08 |
Accrued Expenses | 76.07 | 116.74 | 100.08 | 206.23 | 163.66 | 159.1 |
Short-Term Debt | - | - | 171.47 | - | - | - |
Current Portion of Leases | 8.78 | 15.34 | 26.72 | 9.74 | 7.12 | 7.07 |
Unearned Revenue | 1.42 | 1.2 | 2.51 | 5.98 | 5.76 | 11.94 |
Other Current Liabilities | 231.96 | 192.2 | 318.71 | 404.05 | 199.73 | 171.29 |
Total Current Liabilities | 381.24 | 385.26 | 715.5 | 674.24 | 433.44 | 445.49 |
Long-Term Debt | 973.49 | 970.54 | 490.52 | 597.05 | 412.99 | 215.68 |
Long-Term Leases | 3.16 | 3.82 | 24.97 | 38.01 | 56.01 | 57.72 |
Other Long-Term Liabilities | 124.57 | 124.43 | 121.99 | 124.88 | 55.44 | 6.93 |
Total Long-Term Liabilities | 1,101 | 1,099 | 637.48 | 759.94 | 524.43 | 280.33 |
Total Liabilities | 1,482 | 1,484 | 1,353 | 1,434 | 957.88 | 725.83 |
Common Stock | 1.19 | 1.18 | 1.17 | 1.15 | 1.02 | 0.91 |
Treasury Stock | -61.43 | -61.43 | -21.12 | -21.12 | -21.12 | -21.12 |
Additional Paid-in Capital | 1,802 | 1,793 | 1,804 | 1,808 | 1,487 | 1,341 |
Accumulated Other Comprehensive Income | -3.63 | -2.62 | -1.75 | -1.26 | -1.18 | -0.36 |
Retained Earnings | -1,342 | -1,315 | -780.82 | -719.19 | -606.15 | -626.78 |
Minority Interest | - | - | 190.17 | 178.43 | - | - |
Shareholders' Equity | 396.39 | 415.19 | 1,001 | 1,068 | 859.42 | 693.63 |
Total Liabilities & Equity | 1,879 | 1,899 | 2,544 | 2,680 | 1,817 | 1,419 |
Total Debt | 985.43 | 989.7 | 713.67 | 644.8 | 476.12 | 280.47 |
Net Cash (Debt) | -819.42 | -811.71 | -550.18 | -438.2 | -273.43 | 61.5 |
Net Cash Per Share | -7.23 | -7.11 | -4.80 | -3.94 | -2.92 | 0.71 |
Book Value | 396.39 | 415.19 | 1,001 | 1,068 | 859.42 | 693.63 |
Book Value Per Share | 3.50 | 3.64 | 8.73 | 9.60 | 9.17 | 8.06 |
Tangible Book Value | -867.72 | -864.23 | -816.22 | -800.85 | -306.14 | -12.45 |
Tangible Book Value Per Share | -7.65 | -7.57 | -7.12 | -7.20 | -3.27 | -0.14 |